管路天天泡药液，DEHP往血里迁。医用输液管路无DEHP没验全，安全就是空话。
结论先摆：输液管路，无DEHP耐化学绑一起
医用输液管路是“接触药液的件”：长期输液、多种药液、安全要求。材料要无 DEHP、耐化学、低析出——结论先给：医用输液管路用无 DEHP 的 SEBS 基 TPE 是主流。
医用输液管路最大的坑：数据漂亮，不如试产一跑。报告数据再好，试产不过关就是白搭——试产，是数据的试金石。
医用输液管路是安全件：DEHP 迁移，不是成本问题，是安全问题。材料选对，输液才安心——安全件，别省料钱。
TPE凭啥无DEHP：邻苯全项可报，耐化学可做
医用输液管路用 TPE 的理由：无 DEHP、耐化学可做、低析出、效率高——四条合起来，适合管路。
无 DEHP 是核心：DEHP 迁移是红线。无 DEHP 检测报告写进验收——无 DEHP，不只是卖点。
耐化学不能省：药液多种多样。耐化学测试写进验收——溶胀，就是问题。
走一天泡它：药液、长期、灭菌
药液工况：多种药液。耐化学数据要验——溶胀，就是问题。
长期工况：长期输液。老化数据要验——发硬，就是问题。
灭菌工况：灭菌处理。耐灭菌数据要验——变形，就是问题。
无DEHP-TPE还是PVC：管路上看迁不迁
| 维度 | 无 DEHP TPE | PVC |
|---|
| 无 DEHP | 是 | 需增塑剂 |
| 耐化学 | 可做 | 中 |
| 低析出 | 可做 | 需管控 |
| 成本 | 中 | 低 |
| 批次 | 稳 | 中 |
| 效率 | 挤出 | 挤出 |
表格读法：PVC 便宜但含增塑剂；无 DEHP TPE 安全——替代 PVC，趋势明确。
无 DEHP，是医疗的硬要求。
试产验证三步：浸泡、灭菌、组合
| 步骤 | 内容 | 目的 |
|---|
| 小批试产 | 500 米 | 验证工艺 |
| 灭菌测试 | 标准灭菌 | 验耐性 |
| 药液浸泡 | 72h | 验耐化学 |
表格读法：报告写得再满，不上机跑一批都不作数——试产，是数据的试金石。
试产过了，数据才算数。
两个坑：数据当全部、DEHP漏测
坑一：数据即全部。只看出厂数据不安排试产，量产就容易翻车——试产先行。
坑二：DEHP 漏测。迁移是红线——无 DEHP 检测，必测。
坑三：耐化学漏测。药液溶胀——耐化学测试，必测。
验收三问：邻苯六项、耐药液、批次
三问：无 DEHP 报告有没有、耐化学按什么药液、试产做没做。一验：实际输液实测——三问一验，供应商底细清楚。
试产验证要先行：先跑 500 件试产，再谈放量——试产，是数据的试金石。
留样要成习惯：每批留样，无 DEHP 耐化学按批次复测。批次换料先对比再放量——批次稳，客诉少。
无 DEHP 不只测 DEHP 一项——增塑剂全项（DINP/DIDP/DEHT）都要报，限值按医疗器械标准核。管路壁厚偏差控制在 ±0.05mm 以内，薄壁均匀才不扭结。
无 DEHP 报告是全项检测，不是单测一项。
灭菌后手感变了不是料差——环氧乙烷残留或辐照降解，材料性能在灭菌环节就变了。灭菌方式不同，材料体系就不同。
灭菌后性能下降，先查灭菌方式对不对料。
试产时把“药液浸泡”和“灭菌处理”串起来跑——模拟完整临床使用流程，分开测都过不代表组合过。试产环境要和量产一致，洁净度不能降。
组合测试过了，才算真过。
TPU 是“硬汉”：耐磨耐油，但辐照后容易发黄变脆。选 TPU 管路，先问供应商耐辐照型号。耐灭菌的 TPU，不是普通 TPU 就行。
TPE 软而便宜，TPU 韧而耐灭菌——输液管路长期留置，柔软度和耐灭菌各管一头。短期管路用 TPE，长期留置用 TPU。按留置时间选体系，不是按价格选。
医用输液管路常见问题与对策表
| 现象 | 原因 | 对策 |
|---|
| 发硬 | 长期输液老化 | 换耐老化料 |
| 溶胀 | 药液腐蚀 | 换耐化学料 |
| DEHP 检出 | 链路污染 | 全链路管控 |
| 灭菌变形 | 灭菌不耐 | 换耐灭菌料 |
| 尺寸波动 | 收缩率漂 | 试产验证 |
**无 DEHP 不是印在包装上就行，要出邻苯六项全检报告。
** 医用 TPE 替代 PVC 的核心卖点就是无邻苯，报告按批次出，灭菌后复测一次——别拿出厂报告当最终验收。
科隆客户案例：收缩率不稳尺寸波动，小批试产续三单
重庆一家医疗器械厂，医用输液管路收缩率不稳，尺寸波动大。科隆配合小批试产验证后再放量，尺寸稳定，客户连续三个批次续单。小批试产把尺寸锁死在放量前——尺寸问题，试产阶段就该暴露。
小结
医用输液管路的选型，无 DEHP 先核，试产再跑，数据漂亮不如试产一跑，试产是试金石。
Pipelines are soaked in medication every day, and DEHP migrates into the bloodstream. Medical infusion lines without DEHP have not been fully tested; safety is just empty talk.
Conclusion first: infusion lines, DEHP-free, chemically resistant bundled together
Medical infusion lines are "parts that come into contact with medication solutions": long-term infusion, multiple drug solutions, safety requirements. Materials must be DEHP-free, chemical-resistant, and low precipitation—conclusion first: SEBS-based TPE without DEHP is mainstream for medical infusion lines.
The biggest pitfall in medical infusion lines: good data, better to run trial production. No matter how good the report data is, failing trial production is pointless—trial production is the touchstone for data.
Medical infusion lines are safety components: DEHP migration is not a cost issue, but a safety issue. Choosing the right materials ensures infusion is safe—safe parts, don't skimp on material costs. Why
TPE be DEHP-free: phthalene can be fully recapitulated, chemically resistant can be used
Reasons for using TPE in medical infusion lines: DEHP-free, chemically resistant, low precipitation, high efficiency—all four together, suitable for tubing.
No DEHP is the core: DEHP migration is the red line. No DEHP test report is included in acceptance—no DEHP is not just a selling point.
No chemical resistance can't be saved: There are many types of chemicals. Chemical resistance tests are included in acceptance—swelling is the problem.
Soak it for a day: medicinal solution, long-term, sterilization
Medicinal liquid condition: various medicinal liquids. Chemical resistance data must be tested—swelling is the problem.
Long-term condition: long-term infusion. Aging data must be verified—hardening is the problem.
Sterilization condition: sterilization treatment. Sterilization resistance data must be tested—deformation is the problem.
No DEHP-TPE or PVC: Depends on whether the pipeline can be transferred
| Dimension | No DEHP TPE | PVC |
|---|
| No DEHP | Yes | Plasticizer required |
| Chemical-resistant | Available | Medium |
| Low Output | Operable | Requires Control |
| Cost | Medium | Low |
| Batch | Stable | Medium |
| Efficiency | Extruded | Extruded |
Table reading: PVC is cheap but contains plasticizers; DEHP-free TPE safety—replacing PVC, with a clear trend.
DEHP-free is a strict medical requirement.
Three steps for trial production verification: soaking, sterilization, combination
| Steps | Content | Purpose |
|---|
| Small batch trial production | 500 meters | Process validation |
| Sterilization testing | Standard sterilization | Testing resistance |
| Solution soaking | 72h | Chemical resistance testing |
Table reading: No matter how full the report is, if you don't run a batch without the machine, it doesn't count—trial production is the touchstone of data.
Only after trial production does the data count.
Two pitfalls: data as everything, DEHP missed tests
Pitfall 1: Data is everything. Only looking at factory data without trial production can cause mass production to fail—pilot production comes first.
Pit 2: DEHP missed test. Migration is a red line—no DEHP test, mandatory.
Pit 3: Chemical resistance missed test. Chemical solution swelling—chemical resistance test, mandatory.
Acceptance question 3: phthalmic six-item, resistance solution, batch
Question 3: No DEHP report, chemical resistance used for chemical solution, trial production or not. First inspection: Actual infusion testing—three questions and one inspection, supplier details are clear.
Trial production validation must come first: first run 500 units for trial production, then discuss volume ramp-up—trial production is the touchstone for data.
Make sample retention a habit: retain samples for each batch, and retest chemical resistance by batch for DEHP-free materials. Compare batch material changes before scaling up—stable batch results, fewer customer complaints.
No DEHP Not just testing DEHP — all plasticizers (DINP/DIDP/DEHT) must be reported, with limits verified according to medical device standards. Pipeline wall thickness deviation should be controlled within ±0.05mm; even thin walls prevent kinking.
No DEHP report is a comprehensive test, not a single test.
If the feel changes after sterilization, it's not a material difference—ethylene oxide residue or irradiation degradation changes material properties during the sterilization stage. Different sterilization methods mean different material systems.
Performance declines after sterilization; first check whether the sterilization method matches the materials.
During trial production, link "soaking the medicinal solution" and "sterilization treatment" together—simulate the complete clinical usage process; passing separate tests doesn't mean combination. The trial production environment must be consistent with mass production, and cleanliness must not be compromised.
Only after combined testing is it considered truly passed.
TPU is the "tough guy": wear-resistant and oil-resistant, but easily yellows and becomes brittle after irradiation. When choosing TPU tubing, first ask the supplier about the irradiation-resistant model. Sterile-resistant TPU is not just ordinary TPU.
TPE Soft and cheap, TPU is tough and sterile-resistant—for long-term infusion tubing, one end for softness and sterilization resistance. Use TPE for short-term tubing, TPU for long-term indwelling. Choose the system based on retention time, not price.
Common Issues and Countermeasures Table of Medical Infusion Pipelines
| Phenomenon | Causes | Countermeasures |
|---|
| Stiffness | Long-term Infusion Aging | Replacing Aging-Resistant Material |
| Swelling | Drug Corrosion | Change to chemical-resistant |
| DEHP detection | link contamination | Full chain control |
| Sterilization deformation | Sterilization resistance | Change sterilization resistant material |
| Size fluctuation | Shrinkage fluctuation | Trial production verification |
**No DEHP Not just printed on the packaging; a complete inspection report for six phthalene items must be issued.
** The core selling point of medical TPE replacing PVC is phthalene-free; reports are issued in batches, and after sterilization, a retest is conducted—don't just present the factory report as the final acceptance.
Cologne customer case: unstable shrinkage rate and size fluctuations, three orders for small-batch trial production
A medical device factory in Chongqing, medical infusion pipeline has unstable shrinkage rates and large dimensional fluctuations. Cologne cooperates with small-batch trial production for validation before scaling up, with stable dimensions, and the customer renewed orders for three consecutive batches. Small-batch trial production locks in size before ramp-up—size issues should be exposed during trial production.
Summary
For the selection of medical infusion tubing, prioritize DEHP-free first. Run a trial production before full-scale production. Beautiful data is not as valuable as one trial run; trial production is the touchstone.
